Global Glucagon Injectable Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Glucagon Injectable market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The Global Info Research report includes an overview of the development of the Glucagon Injectable industry chain, the market status of Hospital Pharmacies (Children, Adults), Retail Pharmacies (Children, Adults), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Glucagon Injectable.

Regionally, the report analyzes the Glucagon Injectable markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Glucagon Injectable market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Glucagon Injectable market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Glucagon Injectable industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Children, Adults).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Glucagon Injectable market.

Regional Analysis: The report involves examining the Glucagon Injectable market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Glucagon Injectable market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Glucagon Injectable:
Company Analysis: Report covers individual Glucagon Injectable manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Glucagon Injectable This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).

Technology Analysis: Report covers specific technologies relevant to Glucagon Injectable. It assesses the current state, advancements, and potential future developments in Glucagon Injectable areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Glucagon Injectable market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Glucagon Injectable market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Children
    Adults

Market segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Others

Major players covered
    Fresenius SE & Co. KGaA
    Xeris Pharmaceuticals Inc
    Novo Nordisk A/S
    ILS.Inc
    Amphastar Pharmaceuticals Inc.
    Lilly USA, LLC
    Zealand Pharma A/S.
    Avalon Pharma Pvt. Ltd.

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon Injectable product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glucagon Injectable, with price, sales, revenue and global market share of Glucagon Injectable from 2018 to 2023.
Chapter 3, the Glucagon Injectable competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon Injectable breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Glucagon Injectable market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glucagon Injectable.
Chapter 14 and 15, to describe Glucagon Injectable sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Glucagon Injectable
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Glucagon Injectable Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Children
        1.3.3 Adults
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Glucagon Injectable Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
        1.4.5 Others
    1.5 Global Glucagon Injectable Market Size & Forecast
        1.5.1 Global Glucagon Injectable Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Glucagon Injectable Sales Quantity (2018-2029)
        1.5.3 Global Glucagon Injectable Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Fresenius SE & Co. KGaA
        2.1.1 Fresenius SE & Co. KGaA Details
        2.1.2 Fresenius SE & Co. KGaA Major Business
        2.1.3 Fresenius SE & Co. KGaA Glucagon Injectable Product and Services
        2.1.4 Fresenius SE & Co. KGaA Glucagon Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Fresenius SE & Co. KGaA Recent Developments/Updates
    2.2 Xeris Pharmaceuticals Inc
        2.2.1 Xeris Pharmaceuticals Inc Details
        2.2.2 Xeris Pharmaceuticals Inc Major Business
        2.2.3 Xeris Pharmaceuticals Inc Glucagon Injectable Product and Services
        2.2.4 Xeris Pharmaceuticals Inc Glucagon Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Xeris Pharmaceuticals Inc Recent Developments/Updates
    2.3 Novo Nordisk A/S
        2.3.1 Novo Nordisk A/S Details
        2.3.2 Novo Nordisk A/S Major Business
        2.3.3 Novo Nordisk A/S Glucagon Injectable Product and Services
        2.3.4 Novo Nordisk A/S Glucagon Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Novo Nordisk A/S Recent Developments/Updates
    2.4 ILS.Inc
        2.4.1 ILS.Inc Details
        2.4.2 ILS.Inc Major Business
        2.4.3 ILS.Inc Glucagon Injectable Product and Services
        2.4.4 ILS.Inc Glucagon Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 ILS.Inc Recent Developments/Updates
    2.5 Amphastar Pharmaceuticals Inc.
        2.5.1 Amphastar Pharmaceuticals Inc. Details
        2.5.2 Amphastar Pharmaceuticals Inc. Major Business
        2.5.3 Amphastar Pharmaceuticals Inc. Glucagon Injectable Product and Services
        2.5.4 Amphastar Pharmaceuticals Inc. Glucagon Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Amphastar Pharmaceuticals Inc. Recent Developments/Updates
    2.6 Lilly USA, LLC
        2.6.1 Lilly USA, LLC Details
        2.6.2 Lilly USA, LLC Major Business
        2.6.3 Lilly USA, LLC Glucagon Injectable Product and Services
        2.6.4 Lilly USA, LLC Glucagon Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Lilly USA, LLC Recent Developments/Updates
    2.7 Zealand Pharma A/S.
        2.7.1 Zealand Pharma A/S. Details
        2.7.2 Zealand Pharma A/S. Major Business
        2.7.3 Zealand Pharma A/S. Glucagon Injectable Product and Services
        2.7.4 Zealand Pharma A/S. Glucagon Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Zealand Pharma A/S. Recent Developments/Updates
    2.8 Avalon Pharma Pvt. Ltd.
        2.8.1 Avalon Pharma Pvt. Ltd. Details
        2.8.2 Avalon Pharma Pvt. Ltd. Major Business
        2.8.3 Avalon Pharma Pvt. Ltd. Glucagon Injectable Product and Services
        2.8.4 Avalon Pharma Pvt. Ltd. Glucagon Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Avalon Pharma Pvt. Ltd. Recent Developments/Updates

3 Competitive Environment: Glucagon Injectable by Manufacturer
    3.1 Global Glucagon Injectable Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Glucagon Injectable Revenue by Manufacturer (2018-2023)
    3.3 Global Glucagon Injectable Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Glucagon Injectable by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Glucagon Injectable Manufacturer Market Share in 2022
        3.4.2 Top 6 Glucagon Injectable Manufacturer Market Share in 2022
    3.5 Glucagon Injectable Market: Overall Company Footprint Analysis
        3.5.1 Glucagon Injectable Market: Region Footprint
        3.5.2 Glucagon Injectable Market: Company Product Type Footprint
        3.5.3 Glucagon Injectable Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Glucagon Injectable Market Size by Region
        4.1.1 Global Glucagon Injectable Sales Quantity by Region (2018-2029)
        4.1.2 Global Glucagon Injectable Consumption Value by Region (2018-2029)
        4.1.3 Global Glucagon Injectable Average Price by Region (2018-2029)
    4.2 North America Glucagon Injectable Consumption Value (2018-2029)
    4.3 Europe Glucagon Injectable Consumption Value (2018-2029)
    4.4 Asia-Pacific Glucagon Injectable Consumption Value (2018-2029)
    4.5 South America Glucagon Injectable Consumption Value (2018-2029)
    4.6 Middle East and Africa Glucagon Injectable Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Glucagon Injectable Sales Quantity by Type (2018-2029)
    5.2 Global Glucagon Injectable Consumption Value by Type (2018-2029)
    5.3 Global Glucagon Injectable Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Glucagon Injectable Sales Quantity by Application (2018-2029)
    6.2 Global Glucagon Injectable Consumption Value by Application (2018-2029)
    6.3 Global Glucagon Injectable Average Price by Application (2018-2029)

7 North America
    7.1 North America Glucagon Injectable Sales Quantity by Type (2018-2029)
    7.2 North America Glucagon Injectable Sales Quantity by Application (2018-2029)
    7.3 North America Glucagon Injectable Market Size by Country
        7.3.1 North America Glucagon Injectable Sales Quantity by Country (2018-2029)
        7.3.2 North America Glucagon Injectable Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Glucagon Injectable Sales Quantity by Type (2018-2029)
    8.2 Europe Glucagon Injectable Sales Quantity by Application (2018-2029)
    8.3 Europe Glucagon Injectable Market Size by Country
        8.3.1 Europe Glucagon Injectable Sales Quantity by Country (2018-2029)
        8.3.2 Europe Glucagon Injectable Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Glucagon Injectable Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Glucagon Injectable Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Glucagon Injectable Market Size by Region
        9.3.1 Asia-Pacific Glucagon Injectable Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Glucagon Injectable Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Glucagon Injectable Sales Quantity by Type (2018-2029)
    10.2 South America Glucagon Injectable Sales Quantity by Application (2018-2029)
    10.3 South America Glucagon Injectable Market Size by Country
        10.3.1 South America Glucagon Injectable Sales Quantity by Country (2018-2029)
        10.3.2 South America Glucagon Injectable Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Glucagon Injectable Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Glucagon Injectable Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Glucagon Injectable Market Size by Country
        11.3.1 Middle East & Africa Glucagon Injectable Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Glucagon Injectable Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Glucagon Injectable Market Drivers
    12.2 Glucagon Injectable Market Restraints
    12.3 Glucagon Injectable Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Glucagon Injectable and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Glucagon Injectable
    13.3 Glucagon Injectable Production Process
    13.4 Glucagon Injectable Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Glucagon Injectable Typical Distributors
    14.3 Glucagon Injectable Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Glucagon Injectable Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Glucagon Injectable Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Fresenius SE & Co. KGaA Basic Information, Manufacturing Base and Competitors
    Table 4. Fresenius SE & Co. KGaA Major Business
    Table 5. Fresenius SE & Co. KGaA Glucagon Injectable Product and Services
    Table 6. Fresenius SE & Co. KGaA Glucagon Injectable Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Fresenius SE & Co. KGaA Recent Developments/Updates
    Table 8. Xeris Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
    Table 9. Xeris Pharmaceuticals Inc Major Business
    Table 10. Xeris Pharmaceuticals Inc Glucagon Injectable Product and Services
    Table 11. Xeris Pharmaceuticals Inc Glucagon Injectable Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Xeris Pharmaceuticals Inc Recent Developments/Updates
    Table 13. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
    Table 14. Novo Nordisk A/S Major Business
    Table 15. Novo Nordisk A/S Glucagon Injectable Product and Services
    Table 16. Novo Nordisk A/S Glucagon Injectable Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Novo Nordisk A/S Recent Developments/Updates
    Table 18. ILS.Inc Basic Information, Manufacturing Base and Competitors
    Table 19. ILS.Inc Major Business
    Table 20. ILS.Inc Glucagon Injectable Product and Services
    Table 21. ILS.Inc Glucagon Injectable Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. ILS.Inc Recent Developments/Updates
    Table 23. Amphastar Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
    Table 24. Amphastar Pharmaceuticals Inc. Major Business
    Table 25. Amphastar Pharmaceuticals Inc. Glucagon Injectable Product and Services
    Table 26. Amphastar Pharmaceuticals Inc. Glucagon Injectable Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Amphastar Pharmaceuticals Inc. Recent Developments/Updates
    Table 28. Lilly USA, LLC Basic Information, Manufacturing Base and Competitors
    Table 29. Lilly USA, LLC Major Business
    Table 30. Lilly USA, LLC Glucagon Injectable Product and Services
    Table 31. Lilly USA, LLC Glucagon Injectable Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Lilly USA, LLC Recent Developments/Updates
    Table 33. Zealand Pharma A/S. Basic Information, Manufacturing Base and Competitors
    Table 34. Zealand Pharma A/S. Major Business
    Table 35. Zealand Pharma A/S. Glucagon Injectable Product and Services
    Table 36. Zealand Pharma A/S. Glucagon Injectable Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Zealand Pharma A/S. Recent Developments/Updates
    Table 38. Avalon Pharma Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
    Table 39. Avalon Pharma Pvt. Ltd. Major Business
    Table 40. Avalon Pharma Pvt. Ltd. Glucagon Injectable Product and Services
    Table 41. Avalon Pharma Pvt. Ltd. Glucagon Injectable Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Avalon Pharma Pvt. Ltd. Recent Developments/Updates
    Table 43. Global Glucagon Injectable Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 44. Global Glucagon Injectable Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 45. Global Glucagon Injectable Average Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 46. Market Position of Manufacturers in Glucagon Injectable, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 47. Head Office and Glucagon Injectable Production Site of Key Manufacturer
    Table 48. Glucagon Injectable Market: Company Product Type Footprint
    Table 49. Glucagon Injectable Market: Company Product Application Footprint
    Table 50. Glucagon Injectable New Market Entrants and Barriers to Market Entry
    Table 51. Glucagon Injectable Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Glucagon Injectable Sales Quantity by Region (2018-2023) & (K Units)
    Table 53. Global Glucagon Injectable Sales Quantity by Region (2024-2029) & (K Units)
    Table 54. Global Glucagon Injectable Consumption Value by Region (2018-2023) & (USD Million)
    Table 55. Global Glucagon Injectable Consumption Value by Region (2024-2029) & (USD Million)
    Table 56. Global Glucagon Injectable Average Price by Region (2018-2023) & (USD/Unit)
    Table 57. Global Glucagon Injectable Average Price by Region (2024-2029) & (USD/Unit)
    Table 58. Global Glucagon Injectable Sales Quantity by Type (2018-2023) & (K Units)
    Table 59. Global Glucagon Injectable Sales Quantity by Type (2024-2029) & (K Units)
    Table 60. Global Glucagon Injectable Consumption Value by Type (2018-2023) & (USD Million)
    Table 61. Global Glucagon Injectable Consumption Value by Type (2024-2029) & (USD Million)
    Table 62. Global Glucagon Injectable Average Price by Type (2018-2023) & (USD/Unit)
    Table 63. Global Glucagon Injectable Average Price by Type (2024-2029) & (USD/Unit)
    Table 64. Global Glucagon Injectable Sales Quantity by Application (2018-2023) & (K Units)
    Table 65. Global Glucagon Injectable Sales Quantity by Application (2024-2029) & (K Units)
    Table 66. Global Glucagon Injectable Consumption Value by Application (2018-2023) & (USD Million)
    Table 67. Global Glucagon Injectable Consumption Value by Application (2024-2029) & (USD Million)
    Table 68. Global Glucagon Injectable Average Price by Application (2018-2023) & (USD/Unit)
    Table 69. Global Glucagon Injectable Average Price by Application (2024-2029) & (USD/Unit)
    Table 70. North America Glucagon Injectable Sales Quantity by Type (2018-2023) & (K Units)
    Table 71. North America Glucagon Injectable Sales Quantity by Type (2024-2029) & (K Units)
    Table 72. North America Glucagon Injectable Sales Quantity by Application (2018-2023) & (K Units)
    Table 73. North America Glucagon Injectable Sales Quantity by Application (2024-2029) & (K Units)
    Table 74. North America Glucagon Injectable Sales Quantity by Country (2018-2023) & (K Units)
    Table 75. North America Glucagon Injectable Sales Quantity by Country (2024-2029) & (K Units)
    Table 76. North America Glucagon Injectable Consumption Value by Country (2018-2023) & (USD Million)
    Table 77. North America Glucagon Injectable Consumption Value by Country (2024-2029) & (USD Million)
    Table 78. Europe Glucagon Injectable Sales Quantity by Type (2018-2023) & (K Units)
    Table 79. Europe Glucagon Injectable Sales Quantity by Type (2024-2029) & (K Units)
    Table 80. Europe Glucagon Injectable Sales Quantity by Application (2018-2023) & (K Units)
    Table 81. Europe Glucagon Injectable Sales Quantity by Application (2024-2029) & (K Units)
    Table 82. Europe Glucagon Injectable Sales Quantity by Country (2018-2023) & (K Units)
    Table 83. Europe Glucagon Injectable Sales Quantity by Country (2024-2029) & (K Units)
    Table 84. Europe Glucagon Injectable Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe Glucagon Injectable Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific Glucagon Injectable Sales Quantity by Type (2018-2023) & (K Units)
    Table 87. Asia-Pacific Glucagon Injectable Sales Quantity by Type (2024-2029) & (K Units)
    Table 88. Asia-Pacific Glucagon Injectable Sales Quantity by Application (2018-2023) & (K Units)
    Table 89. Asia-Pacific Glucagon Injectable Sales Quantity by Application (2024-2029) & (K Units)
    Table 90. Asia-Pacific Glucagon Injectable Sales Quantity by Region (2018-2023) & (K Units)
    Table 91. Asia-Pacific Glucagon Injectable Sales Quantity by Region (2024-2029) & (K Units)
    Table 92. Asia-Pacific Glucagon Injectable Consumption Value by Region (2018-2023) & (USD Million)
    Table 93. Asia-Pacific Glucagon Injectable Consumption Value by Region (2024-2029) & (USD Million)
    Table 94. South America Glucagon Injectable Sales Quantity by Type (2018-2023) & (K Units)
    Table 95. South America Glucagon Injectable Sales Quantity by Type (2024-2029) & (K Units)
    Table 96. South America Glucagon Injectable Sales Quantity by Application (2018-2023) & (K Units)
    Table 97. South America Glucagon Injectable Sales Quantity by Application (2024-2029) & (K Units)
    Table 98. South America Glucagon Injectable Sales Quantity by Country (2018-2023) & (K Units)
    Table 99. South America Glucagon Injectable Sales Quantity by Country (2024-2029) & (K Units)
    Table 100. South America Glucagon Injectable Consumption Value by Country (2018-2023) & (USD Million)
    Table 101. South America Glucagon Injectable Consumption Value by Country (2024-2029) & (USD Million)
    Table 102. Middle East & Africa Glucagon Injectable Sales Quantity by Type (2018-2023) & (K Units)
    Table 103. Middle East & Africa Glucagon Injectable Sales Quantity by Type (2024-2029) & (K Units)
    Table 104. Middle East & Africa Glucagon Injectable Sales Quantity by Application (2018-2023) & (K Units)
    Table 105. Middle East & Africa Glucagon Injectable Sales Quantity by Application (2024-2029) & (K Units)
    Table 106. Middle East & Africa Glucagon Injectable Sales Quantity by Region (2018-2023) & (K Units)
    Table 107. Middle East & Africa Glucagon Injectable Sales Quantity by Region (2024-2029) & (K Units)
    Table 108. Middle East & Africa Glucagon Injectable Consumption Value by Region (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Glucagon Injectable Consumption Value by Region (2024-2029) & (USD Million)
    Table 110. Glucagon Injectable Raw Material
    Table 111. Key Manufacturers of Glucagon Injectable Raw Materials
    Table 112. Glucagon Injectable Typical Distributors
    Table 113. Glucagon Injectable Typical Customers
List of Figures
    Figure 1. Glucagon Injectable Picture
    Figure 2. Global Glucagon Injectable Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Glucagon Injectable Consumption Value Market Share by Type in 2022
    Figure 4. Children Examples
    Figure 5. Adults Examples
    Figure 6. Global Glucagon Injectable Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Glucagon Injectable Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Pharmacies Examples
    Figure 9. Retail Pharmacies Examples
    Figure 10. Online Pharmacies Examples
    Figure 11. Others Examples
    Figure 12. Global Glucagon Injectable Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Glucagon Injectable Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Glucagon Injectable Sales Quantity (2018-2029) & (K Units)
    Figure 15. Global Glucagon Injectable Average Price (2018-2029) & (USD/Unit)
    Figure 16. Global Glucagon Injectable Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Glucagon Injectable Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Glucagon Injectable by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Glucagon Injectable Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Glucagon Injectable Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Glucagon Injectable Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Glucagon Injectable Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Glucagon Injectable Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Glucagon Injectable Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Glucagon Injectable Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Glucagon Injectable Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Glucagon Injectable Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Glucagon Injectable Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Glucagon Injectable Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Glucagon Injectable Average Price by Type (2018-2029) & (USD/Unit)
    Figure 31. Global Glucagon Injectable Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Glucagon Injectable Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Glucagon Injectable Average Price by Application (2018-2029) & (USD/Unit)
    Figure 34. North America Glucagon Injectable Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Glucagon Injectable Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Glucagon Injectable Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Glucagon Injectable Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Glucagon Injectable Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Glucagon Injectable Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Glucagon Injectable Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Glucagon Injectable Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Glucagon Injectable Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Glucagon Injectable Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Glucagon Injectable Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Glucagon Injectable Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Glucagon Injectable Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Glucagon Injectable Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Glucagon Injectable Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Glucagon Injectable Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Glucagon Injectable Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Glucagon Injectable Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Glucagon Injectable Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Glucagon Injectable Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Glucagon Injectable Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Glucagon Injectable Market Drivers
    Figure 75. Glucagon Injectable Market Restraints
    Figure 76. Glucagon Injectable Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Glucagon Injectable in 2022
    Figure 79. Manufacturing Process Analysis of Glucagon Injectable
    Figure 80. Glucagon Injectable Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Companies Mentioned

Fresenius SE & Co. KGaA
Xeris Pharmaceuticals Inc
Novo Nordisk A/S
ILS.Inc
Amphastar Pharmaceuticals Inc.
Lilly USA, LLC
Zealand Pharma A/S.
Avalon Pharma Pvt. Ltd.